Biodesix Inc (BDSX): Price-to-Revenue Coefficient

Symbol and logo of brand Biodesix Inc (BDSX)

Stable income from insurance payouts supports margins, which is reflected in the price/sales multiple dynamics of Biodesix, Inc. (BDSX). Growth is driven by rapid blood tests as an alternative to biopsies, while AI-powered robotics accelerate DNA sequencing. 1.00 represents the current value of the indicator, allowing for the visualization of business valuation deviations from revenue and the effective protection of capital against market drawdowns.

Biodesix (BDSX): Price-to-Revenue Ratio from 07/04/2022 to 11/13/2026

Analytical breakdowns for Biodesix Corp (BDSX)

- current quotes and average value forecast:
Market Price biodesix.com|BDSX - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Biodesix Corp|BDSX - Enterprise Value
- company book value details:
Net Assets per Share Biodesix|BDSX - Company Book Value|Market Capitalization to Book Value biodesix.com|BDSX - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Equity Biodesix, Inc.|BDSX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Biodesix Corporation|BDSX - Company Debts|Debts to Book Value Biodesix Corp|BDSX - Company Long-Term Debts|Company Short-Term Indebtedness Biodesix|Immediate Liquidity biodesix.com
- net income and valuation ratios data:
BDSX - Company Net Income|Company Profit Forecast Biodesix, Inc.|BDSX - P/E Multiple|Market Cap to Projected Earnings Biodesix Inc|BDSX - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Biodesix Corp|BDSX - Operating profit before deduction of amortization|Earnings per share for the trailing year Biodesix|BDSX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months biodesix.com|BDSX - Earnings per share growth in current year|Projected earnings per share growth rate for next year Biodesix, Inc.
- total revenue and sales volume data:
BDSX - Revenue and Sales Volume|Company Future Sales Volume biodesix.com|BDSX - Market Cap to Revenue|Market Cap to Expected Sales Ratio Biodesix Corp
Fundamental company analysis:BDSX - biodesix.com
Product sample of Biodesix, Inc.

The P/S ratio determines the market value of a business relative to its annual sales volume, measuring the premium the market is willing to pay per unit of revenue. For Biodesix, Inc. (BDSX), a leader in AI-driven lung cancer diagnostics, this metric reflects the capitalization of its scientific and technical potential. By analyzing the company's revenue valuation, an investor can observe the demand dynamics for precision biopsy. Sharp fluctuations in the line indicate a shift in expectations regarding the pace of innovation commercialization.

Competing companies

CAI - Price to Sales|Price-to-Revenue Ratio Guardant Health GH|Price-to-Revenue Coefficient Veracyte Inc (VCYT)|Celcuity Corp - P/S Multiple|Price-to-Revenue Coefficient GRAIL Bio GRAL|Myriad Genetics, Inc. (MYGN) - Price-to-Revenue Ratio|CSTL - Price-to-Revenue Coefficient|BNR (Burning Rock) - P/S Multiple|Price-to-Revenue Ratio VNRX|P/S Multiple PRPO|Price-to-Revenue Coefficient check-cap.com|Price-to-Revenue Ratio Mainz Biomed MYNZ|oncocyte.com (OCX) - Price to Sales